Citation Impact
Citing Papers
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Pharmacological properties of Salvia officinalis and its components
2017 Standout
Parenteral Anticoagulants
2008
Parenteral Anticoagulants
2012 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: A prospective, randomised study comparing two doses of parnaparin (BAFLUX STUDY)
2009
Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms
2019 Standout
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
The safety of dosing dalteparin based on actual body weight for the treatment of acute venous thromboembolism in obese patients
2004
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Heparin Thromboprophylaxis in Gastric Bypass Surgery
2003
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Topical Agents in the Treatment of Rheumatic Pain
2008
Abyssomicins from the South China Sea Deep‐Sea Sediment Verrucosispora sp.: Natural Thioether Michael Addition Adducts as Antitubercular Prodrugs
2012
New insights into the use of currently available non-steroidal anti-inflammatory drugs
2015
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies
2003
Antithrombotic Therapy for VTE Disease
2012 Standout
Heparin and Low-Molecular-Weight Heparin
2004
Activity of quinupristin/dalfopristin against gram-positive bacteria: clinical applications and therapeutic potential
1997
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Histopathology of Common Tendinopathies
1999
Prevention of Venous Thromboembolism
2004 Standout
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Continuous Intravenous Heparin Infusion Prevents Peri-operative Thromboembolic Events in Bariatric Surgery Patients
2005
Prevention of Venous Thromboembolism
2008 Standout
Obesity in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial
2008
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Tendon Injury and Tendinopathy
2005 Standout
Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients
2009
Pharmacokinetics and Pharmacodynamics of the Nitroimidazole Antimicrobials
1999
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Infective endocarditis
2004 Standout
Safety of Prolonged High-Dose Levofloxacin Therapy for Bone Infections
2007
Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
2007
Enoxaparin Dosing and Associated Risk of In-Hospital Bleeding and Death in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
2007
Quinupristin-Dalfopristin Combined with β-Lactams for Treatment of Experimental Endocarditis Due to Staphylococcus aureus Constitutively Resistant to Macrolide-Lincosamide-Streptogramin B Antibiotics
2000
A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients
1987
Marine natural products
2015 Standout
Anticoagulation: Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings
2009
In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms
1993
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive Bacteria
2003 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Riluzole as a Neuroprotective Drug for Spinal Cord Injury: From Bench to Bedside
2015
Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis
1997
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium
1997
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500
1995
In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis
1994
Works of A. Le Liboux being referenced
A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500
1992
Secnidazole concentrations in plasma and crevicular fluid after a single oral dose
1993
Influence of rifampin on the pharmacokinetics of pefloxacin
1991
Simultaneous high-performance liquid chromatographic determination of quinupristin, dalfopristin and their main metabolites in human plasma
1998
Single‐ and Multiple‐Dose Pharmacokinetics of Riluzole in White Subjects
1997
Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy
1999
A Comparison of the Pharmacokinetics and Tolerability of Riluzole after Repeat Dose Administration in Healthy Elderly and Young Volunteers
1999
The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers
2002
Pharmacokinetics in man of acebutolol and hydrochlorothiazide as single agents and in combination
1983
An open, randomized study of ketoprofen in patients in surgery for Achilles or patellar tendinopathy.
1997